StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Saturday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 4.7 % NYSE BTX opened at $1.88 on Friday. The firm’s 50 day moving average is $1.45 and its 200-day moving average […]